IL6 and cancer: This is supported by experimental models whereby pro-inflammatory cytokines, including interleukin-1 (IL-1), IL-6 and tumour necrosis factor-ά (TNF), have been reported as mediators of both anorexia and skeletal muscle proteolysis [15], the key components of weight loss in patients with cancer.